Phase 3 Venous Thromboembolism Clinical Trials
16 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–16 of 16 trials
Recruiting
Phase 3
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled14 locationsNCT07213778
Recruiting
Phase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled41 locationsNCT07015905
Recruiting
Phase 3
Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis
Venous Thromboembolism (VTE)Postpartum
Marc Blondon9,200 enrolled1 locationNCT07140211
Recruiting
Phase 3
DOAC - Dosing Options in AntiCoagulation Prophylaxis
CancerVTE (Venous Thromboembolism)
University of Vermont996 enrolled1 locationNCT07005024
Recruiting
Phase 3
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Metastatic Pancreatic CancerVenous ThromboembolismLocally Advanced Pancreatic Adenocarcinoma
Quercis Pharma AG480 enrolled3 locationsNCT06861088
Recruiting
Phase 3
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
Venous ThromboembolismGastro Intestinal BleedingBlood Clot
Ottawa Hospital Research Institute360 enrolled7 locationsNCT06393868
Recruiting
Phase 3
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
Venous ThromboembolismBlood ClotPost Thrombotic Syndrome
Ottawa Hospital Research Institute2,700 enrolled31 locationsNCT04319627
Recruiting
Phase 3
Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
Venous Thromboembolism
Ottawa Hospital Research Institute150 enrolled3 locationsNCT06440694
Recruiting
Phase 3
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+3 more
University Hospital, Angers1,424 enrolled35 locationsNCT06195540
Recruiting
Phase 2Phase 3
VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Urologic CancerVenous Thromboembolism
Ottawa Hospital Research Institute120 enrolled1 locationNCT05920343
Recruiting
Phase 3
Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters
CancerVenous Thromboembolism
Ottawa Hospital Research Institute1,828 enrolled11 locationsNCT05029063
Recruiting
Phase 3
ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
Hip Arthroplasty, TotalPrevention of Venous Thromboembolism
Prof. Stavros Konstantinides, MD2,932 enrolled6 locationsNCT06611319
Recruiting
Phase 3
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
ElderlyVenous ThromboembolismAnticoagulant
Arianna Anticoagulazione Foundation1,455 enrolled1 locationNCT04257487
Recruiting
Phase 3
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University200 enrolled7 locationsNCT04066764
Recruiting
Phase 3
VTE Prevention Following Total Hip and Knee Arthroplasty
Venous Thromboembolism
Sudeep Shivakumar5,400 enrolled1 locationNCT04075240
Completed
Phase 3Phase 4
Assessment of microbleeding after prophylaxis with enoxaparin or rivaroxaban against venous thromboembolic disease following hip and knee surgery
Prevention and treatment of venous thromboembolism (VTE); comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip and knee arthroplasty.
Launceston General Hospital1,060 enrolled1 locationACTRN12609000762257